Ulthera, Inc., a therapeutic ultrasound medical device company serving the aesthetics market, today announced that it has received $22.5 million in a Series B round that was led by New Enterprise Associates (NEA). Existing investor 3i also participated in the round.
Chip Linehan, NEA General Partner, who will join the Ulthera Board of Directors.
INFO SOURCES
Ulthera, Inc.
FIRMS
Ulthera, Inc. develops, sells and markets novel therapeutic ultrasound-based medical devices into the expanding medical aesthetic market. This market is defined by elective procedures for consumers wishing to achieve cosmetic improvement in their appearance. The company is targeting the non-invasive face lift and skin rejuvenation market segment, which will exceed $4 B worldwide in 2010. Ulthera was founded in 2004 and spun-off from Guided Therapy Systems, LLC, a Mesa, Arizona based ultrasonic medical technologies company.
Supporting Material
